Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

Go back to Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
(NASDAQ: PLRX) Delayed: 1.17 +0.01 (0.86%)
Previous Close $1.16    52 Week High
Open $1.15    52 Week Low
Day High $1.18    P/E N/A 
Day Low $1.15    EPS
Volume 484,797